Update on the Association Between Anticholinergics and Dementia Risk (BBC News / BMJ)

Summary

A new statistical study has confirmed an association between use of certain anticholinergic drugs (commonly prescribed for the treatment of depression, Parkinson’s Disease and bladder problems) and a heightened risk of developing dementia.

Other anticholinergics, taken to treat hay fever, travel sickness or stomach cramps, appear not to carry a similar association.

Experts suggest consumers should not be over-worried, yet.

“It is important to be cautious about associations as they do not prove causation”. Prof Martin Rossor. Dementia Research.

Full Text Link

Reference

Westbrook, I. (2018). Dementia risk linked to some medicines. London: BBC Health News, April 26th 2018.

This relates to:

Full Text Link

Reference

Richardson, K. Fox, C. [and] Maidment, I. [et al]. (2018). Anticholinergic drugs and risk of dementia: case-control study. BMJ. April 25th 2018; 361: k1315.

See also the BMJ Editorial:

Full Text Link

Reference

Gray, SL [and] Hanlon, JT. (2018). Anticholinergic drugs and dementia in older adults. BMJ.  April 25th 2018; 361: k1722.

“People who’d taken anticholinergic antidepressants, drugs for Parkinson’s Disease, and drugs used for urinary incontinence were more likely to have developed dementia. Those who’d taken anticholinergic drugs for cardiovascular or gastrointestinal conditions did not have an increased risk”.

An NHS Choices Behind the Headlines critical appraisal offers a sense of proportion.

“It is also important to stress that the researchers think the risk to individuals is small”.

Full Text Link

Reference

Some antidepressants and incontinence drugs linked to dementia. London: NHS Choices; Behind the Headlines, April 26th 2018.

Advertisements

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Acute Hospitals, Alzheimer's Society, BBC News, Community Care, Depression, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Parkinson's Disease, Quick Insights, Statistics, UK, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.